Sponsor pipeline

Teva Branded Pharmaceutical Products R&D LLC clinical trial pipeline

Get alerts when Teva Branded Pharmaceutical Products R&D LLC's trials change

9 active trials 4 recruiting 2 Phase 3 3 disease areas 8 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.

Notable

TEV-53408 · Vitiligo

Enrollment reopened

Teva Branded Pharmaceutical Products R&D LLCPhase 1 NCT06625177 Registry history of NCT06625177 on ClinicalTrials.gov (opens the registry)

Updated Oct 9, 2026

Show 4 trials with minor changes only

Minor

Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Enrollment closed, study ongoing

Also in this update: Primary and study completion pushed from Sep 19, 2026 to Nov 2, 2026; Final enrollment: 649 participants (planned 724)

Teva Branded Pharmaceutical Products R&D LLCPhase 3 NCT06664619 Registry history of NCT06664619 on ClinicalTrials.gov (opens the registry)

Updated Oct 6, 2026
Minor

TOPAS-MSA · If TEV-56286 is Effective · Multiple System Atrophy

Enrollment closed, study ongoing

Teva Branded Pharmaceutical Products R&D LLCPhase 2 NCT06568237 Registry history of NCT06568237 on ClinicalTrials.gov (opens the registry)

Updated Oct 7, 2026
Minor

If TEV-56286 is Effective in Relieving Multiple System Atrophy

Trial sites expanded: 36 → 40 locations

Teva Branded Pharmaceutical Products R&D LLCPhase 2 NCT07197866 Registry history of NCT07197866 on ClinicalTrials.gov (opens the registry)

Updated Sep 28, 2026
Minor

TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Completion moved earlier from Mar 8, 2031 to Jan 31, 2027

Teva Branded Pharmaceutical Products R&D LLCPhase 2 NCT05668013 Registry history of NCT05668013 on ClinicalTrials.gov (opens the registry)

Updated Oct 6, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1		3
Phase 2		4
Phase 3		2

Active trials

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT06052267	A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate…	Asthma	Active, Not Recruiting	2026-10-08
NCT06664619	A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of…	Asthma	Active, Not Recruiting	2026-10-06
Phase 2
NCT07197866	An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy	Multiple System Atrophy	Recruiting	2026-10-09
NCT06568237	A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple…	Multiple System Atrophy	Active, Not Recruiting	2026-10-09
NCT06807463	A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease	Celiac Disease	Active, Not Recruiting	2026-10-09
NCT05668013	A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative…	Crohn Disease	Active, Not Recruiting	2026-10-06
Phase 1
NCT06625177	A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo	Vitiligo	Recruiting	2026-10-09
NCT07674940	A Trial to Assess TEV-56286 at Different Doses in Healthy Participants	Healthy Volunteers	Recruiting	2026-09-08
NCT06480552	An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor…	Advanced Solid Tumors	Recruiting	2026-06-04

Disease areas by active trials

Asthma (2) · Crohn's Disease (1) · Ulcerative Colitis (1)

Get alerts when Teva Branded Pharmaceutical Products R&D LLC's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free